Pharmalot… Pharmalittle… Good Morning
Make a commentBy Ed Silverman // August 11th, 2010 // 6:09 am
Top of the morning to you. And a sunny one it is. Hope your day is getting off to a good start. As for us, we have the usual laundry list of meetings and deadlines, which calls for a cup of stimulation or three. So please join us as we brace for day ahead. And of course, drop us a line if you hear something interesting. We always enjoy a bit of insight. Meanwhile, have a great day…
Gilead May Get FDA Warning Letter (San Francisco Business Journal)
Genzyme Will Need An Extra Year To Fix Manufacturing Woes (Bloomberg News)
Lilly To Lay Off 500 More Employees (Indianapolis Star)
Merck Prostate Cancer Merits More Attention: Study (Bloomberg News)
Sanofi Strikes Personalized Medicine Deal With Scripps (PharmaTimes)
Leave a Comment
Subscribe
Comments feed for this post only.
Tags
Eli Lilly, Genzyme, Gilead Sciences, Merck, Personalized Medicine, Proscar, Sanofi Aventis, Scripps Genomic Medicine